Wednesday, July 3, 2019

Oral Cancer Treatment Market Current Trends and Future Aspect Analysis 2026

Oral or mouth cancer usually occur on the surfaces of tongue, lips, cheek, gums, tonsils and salivary glands. An oral cancer is a type of head and neck cancer; and it appears in the form of a tumor in the mouth. Oral cancers can be benign or malignant. Benign tumors can be removed with the help of surgery. 90% of malignant oral cancers comprise of squamous cell carcinoma, which could spread to other parts of the body. According to the Oral Cancer Foundation, every year around 53,000 new oral cancer cases are diagnosed and more than 9,750 people succumb to the disease in the U.S. Oral cancer accounts for 4% of total cancer cases and causes 2.2% of deaths in the U.S. In western countries, prevalence of oral cancer is 2% to 6% of the total cancer cases. In Asia Pacific, the oropharyngeal cancer is more common among men than women. According to the National Cancer Institute, 60% of people with oral cancer survive for five years or more and 70% to 90% of people with Stage 1 or 2 cancer survive for more than 5 years.


Increase in incidence of oral cancers, surge in health care expenditure, and rise in risk factors such as growing age, increase in HPV16 are some factors driving the global oral cancer treatment market. Additionally, increasing usage of tobacco worldwide is a major factor driving the oral cancer treatment market. According to a report by the World Health Organization (WHO), the worldwide tobacco use is 4 Million which is growing annually and death caused due to tobacco is likely to reach 10 million by 2020. Rising alcohol consumption across the globe is also another major factor causing oral cancer. This, in turn, is likely to propel the global oral cancer treatment market. Moreover, rise in patient population and high investments by governments for providing better oral cancer treatment are anticipated to propel the market during the forecast period. However, ignoring early symptoms of oral cancer and lack of awareness about the disease, especially in developing countries is likely to restrain the global market.

Global oral cancer treatment market can be segmented based on type, treatment, end-users, and region. Based on type of oral cancer, the market can be classified into verrucous carcinoma, squamous cell carcinoma, minor salivary gland cancers, and others. Based on treatment, the global oral cancer treatment market can be categorized into surgery, radiation therapy, targeted therapy, chemotherapy, and others. In terms of end-users, the global market can be divided into hospitals, specialized cancer centers, and others.


In terms of region, the global oral cancer treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in demand for surgical therapies for the treatment of oral cancer and rise in investment by governments in research & development to improve treatments boost the global market. North America dominated the global market in 2017 and this trend is projected to continue during the forecast period owing to the rising health care investments in the region and prevalence of oral cancer. Europe is a major region for the oral cancer treatment market owing to the availability of funds for oral cancer, huge patient population, and high income of people in the region. The oral cancer treatment market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. Rise in tobacco usage, increase in smoking, rapidly expanding health care industry, growing patient population, and high unmet needs are likely to drive the oral cancer treatment market in the region. Further, favorable government policies and rise in disposal income are anticipated to propel the oral cancer treatment market in the region during the forecast period.



Major players operating in the global oral cancer treatment market include Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Acute Repetitive Seizures Market : Global Market Revenue and Share by Manufacturers

The acute repetitive seizure is a condition that occurs in patients with drug-refractory epilepsy. It is also known as cluster seizure, seizure flurry, breakthrough seizure, seizure cluster, serial seizure, or prolonged seizure. The acute repetitive seizure is characterized by the occurrence of seizures within short intervals, which could be within hours or even a few minutes. The frequency of occurrence of these seizures depends upon the type of epilepsy such as mesial temporal lobe epilepsy and the patient characteristics. Three catamenial seizures occur within two premenstrual days in women with mesial temporal lobe epilepsy. Rectal gels and nasal sprays are used for the management of acute repetitive seizures.


Increase in the number of clinical trials, a rise in emphasis on the launch of new therapies, and the surge in demand for nasal sprays for the treatment of epilepsy are the major factors projected to drive the global acute repetitive seizures market. Additionally, an increase in the number of regulatory approvals and promising drugs in the pipeline is anticipated to fuel the growth of the acute repetitive seizures market during the forecast period. For instance, in April 2018, UCB S.A. announced that the Food and Drug Administration (FDA) accepted a new drug application (NDA) for Nayzilam (midazolam) nasal spray indicated for the treatment of seizures such as seizure clusters and acute repetitive seizures. This could result in the approval of the drug in early 2019, making it the first ever medication approved by the FDA in more than 17 years.


The global acute repetitive seizures market can be segmented based on product, route of administration, distribution channel, and region. In terms of product, the acute repetitive seizures market can be divided into USL-261, VALTOCO, AZ-002, Diastat rectal gel, and others. Based on the route of administration, the global acute repetitive seizures market can be classified into nasal, oral, rectal, and others. The nasal segment is anticipated to expand at the fastest CAGR during the forecast period due to shifting from rectal to nasal route of administration and increase in the number of patients preferring nasal sprays due to ease of administration. In terms of the distribution channel, the acute repetitive seizures market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is expected to expand at the fastest CAGR owing to increase in the availability of medications for serious disease conditions at these pharmacies, ease of access, an increase in the chain of retail pharmacies supplying medications for acute repetitive seizures.

The global acute repetitive seizures market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest market share during the forecast period. The acute repetitive seizures market in the region is driven by an increase in the number of pharmaceutical companies engaged in new drug development and rise in prevalence of epileptic seizures. In September 2018, Neurelis, Inc., a pharmaceutical company based in San Diego, the U.S., submitted a New Drug Application (NDA) with the FDA for VALTOCO as a treatment for epilepsy patients with acute repetitive seizures. The acute repetitive seizures market in Europe is anticipated to grow at a rapid pace from 2018 to 2026 due to rise in investment in research and development in the field of neurology, increase in funds offered by the government, and surge in demand for medications for epilepsy. The market in the Asia Pacific is expected to expand at the fastest CAGR during the forecast period driven by rising in awareness about the treatment of neurological disorders and increase in demand for new drug formulations for treating serious conditions in neurology.



Key players operating in the global acute repetitive seizures market are UCB S.A., Neurelis, Inc., Alexza Pharmaceuticals, and Valeant Pharmaceuticals North America LLC.

Bone Cement Delivery Systems Market Development Trends & Competitive Analysis by Leading Industry Players

Global Bone Cement Delivery Systems Market: Overview 

With the growing incidence of osteoporosis across the globe has led the demand in the global bone cement delivery systems market. Osteoporotic fracture includes fracture in hip, spine, shoulder, knee, or wrist has grown approximately to 8.9 million across the globe. Thus with the rising number of people undergoing this condition is expected to drive the demand in the global bone cement delivery systems market.

Additionally, the rising number of hip and knee replacement is also fueling growth in this market. In the U.S. itself, hip replacement figure has reached to 572,000 and knee replacement will increase to 3.5 million by 2030. With growing hip and knee replacements, are expected to fuel the demand in the global bone cement delivery systems market.


In addition to these drivers, other factors related to regional growth and increasing competition in the market influence the growth in this market. Rising trends and acceptance of advanced ways and methods might further boost growth for bone cement delivery systems. With all these information available at one place in a systematic manner helps the key market participants to take well-analyzed decisions.

Global Bone Cement Delivery Systems Market: Notable Developments 

Companies are making deliberate efforts to enhance the services of bone cement delivery systems for better placement while treating the patient.  Leading players seems to engage in various organic and inorganic activities to get a stronger hold in the global market.

The bone cement delivery systems has found it application in various surgical procedures such as  kyphoplasty, hip arthroplasty, vertebroplasty, and knee arthroplasty that will augment growth in this market. One advanced is seen in the kyphoplasty is the addition of magnetic particles in surgical cement that helps in healing spinal fractures. These nanoparticles could be guided straight to lesions near the fractures according to the recent research. This advance procedure will help in delivery bone cement with an effective manner and help in faster healing.


More research is also taking place that will augment growth of the bone cement delivery systems. Players are also making significant efforts to enhance growth in this market. It include Medtronic, Merit Medical Systems, MEDINAUT™-X IBE System, Smith & Nephew, Synimed, Stryker, Spirit Spine, Zimmer Biomet, Biopsybell, and APV Synicem Vertebroplasty System.

Rising Number of Osteoporotic Fractures to Enhance Growth in North America Bone Cement Delivery Systems Market 

Detailed description of regions where the growth of bone cement delivery systems is high includes Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. Of these, North America may hold a leading share in the global bone cement delivery systems market. An increasing number of accidents leading to fractures and bone rupture have led the demand in North America bone cement delivery systems market. According to the data released by the Centers for Disease Control and Prevention report, nearly about 4 million people visit the emergency department due to fractures. Moreover, the high cost associated with osteoporotic fractures has also offered high growth opportunities in this market.


Asia Pacific is also expected to contribute substantially to the growth of the global bone cement delivery systems market. China and India are considered major countries for the growth of the bone cement delivery system due to the growing incidence of dental and orthopedic surgeries. In 2017, the International Osteoporosis Foundation recorded 8.9 million fractures. Moreover, growing acceptance for general prosthetic fixation and the growing number of dental diseases and knee surgeries has further augmented growth in the global bone cement delivery systems market.


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Thursday, June 27, 2019

Cranial Access and Decompression Market Analysis & Key Business Strategies by Leading Industry Players

Global Cranial Access and Decompression Market: Overview

Surgical procedure carried out to relieve excess pressure in the cranium is known as cranial decompression. Two types of surgeries are carried out by surgeons to relieve cranial pressure: microvascular decompression and balloon decompression. Microvascular decompression involves the placement of Teflon (material used for cranial decompression) between the nerve and the blood vessel that leads to decompression. In case of balloon decompression, a balloon is passed through the end of the needle that is inserted in the skull. The balloon is inflated enough to damage the trigeminal nerve, blocking the pain signals.


Global Cranial Access and Decompression Market: Key Trends

The cranial access and decompression market is expected to expand during the forecast period. Increase in number of brain injuries, availability of neurological procedures in hospitals & ambulatory surgical centers, and rise in awareness about indications for cranial decompression are key factors estimated to drive the market in the near future. Furthermore, strengthening health care system and availability of well-equipped neurological centers are projected to boost the market during the forecast period. However, product recalls by regulatory authorities such as the U.S. Food and Drug Administration (FDA) are likely to hamper the market in the near future.

Global Cranial Access and Decompression Market: Segmentation

The global cranial access and decompression market can be segmented based on product, indication, end-user, and region. In terms of product, the market can be divided into motors, ultrasonic aspirators, and cranial access kits.  Based on indication, the market can be segregated into trigeminal neuralgia, traumatic brain injury, and others. The trigeminal neuralgia segment is expected to expand at a rapid pace during the forecast period due to the increase in incidence of trigeminal neuralgia among patients suffering from multiple sclerosis. In terms of end-user, the global market can be segregated into hospitals, ambulatory surgical centers, and neurological centers. Based on end-user, the hospitals segment is expected to hold major share of the market during the forecast period due to an increase in the number of neurological procedures and presence of skilled & experienced health care providers such as neurological surgeons.


Global Cranial Access and Decompression Market: Regional Analysis

Based on region, the global cranial access and decompression market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cranial access and decompression market in 2018. In North America, the U.S. is anticipated to constitute key share of the market, followed by Canada, during the forecast period. The  market in the U.S. is driven by the presence of medical device manufacturers offering neurological devices and instruments, increase in the prevalence of neurological disorders, and easy access to quality care services in the country. The market in Europe is projected to expand at a rapid pace during the forecast period, with Germany anticipated to capture the largest share of the market. Increase in the number of market players engaged in new product development for the treatment of neurological disorders & trauma injuries and increase in demand for advanced medical technologies for surgical procedures are factors projected to augment the market in Europe. The market in In Asia Pacific exhibits significant potential. This offers lucrative opportunities a large number of health care providers that offers surgical procedures for neurology. Hospitals and other health care institutes in Japan and China are striving to adopt health care technologies. They also strive to offer surgical procedures in a cost-effective manner. Japan also maintains a data bank to keep track of trauma injuries and sub-sequent consumption of medical resources in intensive care units. These factors provide growth opportunities for the market in Asia Pacific.


Global Cranial Access and Decompression Market: Competitive Landscape


Key players operating in the global cranial access and decompression market are Stryker, DePuy Synthes, Integra LifeSciences, Natus Medical Incorporated, joimax GmbH, elliquence, and Carevature Medical Ltd.

Paranasal Sinus Cancer Market Global Competitive Analytics and Insights 2027

Global Paranasal Sinus Cancer Market: Overview

Paranasal sinuses and nasal cavity occupy a small anatomical location. These have same site of origin of some of the more complex, morphologically diverse group of tumors in the whole human body. Paranasal sinuses include seromucinous glands, neoplasms from mucosal epithelium, bone, soft tissues, cartilage, the odontogenic apparatus, haematolymphoid cells, and neuroectodermal/neural tissue. Multitudinous tumors are indistinguishable from those found anywhere in the body. However, a few of these are unique because of their site, such as the olfactory neuroblastoma. The affected part, nasal cavity, is located at the back of the nose through which the air is passed to the throat. The air-filled place surrounding the nasal cavity is called paranasal sinuses. Paranasal sinuses have four other fragments: ethmoid sinus (placed on the bridge of the nose and between the eyes), maxillary sinus (situated at the cheeks), sphenoid sinus (situated behind the ethmoids), and frontal sinus (above the eyes). Maxillary sinus is located inside the maxillary bone. The floor of the sinus is placed lower, near the first molar teeth and second premolar and it lies between 3 mm and 5 mm underneath the nasal floor. Ethmoid complex are a pair complex sinuses with 3 to 18 cells. These are divided into posterior, middle, and anterior or with respect to the site of ostia. Frontal sinus is a pair of sinuses located between the external and internal cranial tables. These drain from a nasofrontal duct into either the frontal recess or into the anterior infundibulum. The adult sphenoid sinus is about 23 mm long, 17mm wide, and 20 mm high. The sphenoid sinus septum is anteriorly aligned or in the midline with the nasal septum of the part.


Imaging is a vital diagnostic process in detecting the need for surgical approach. It is termed as an integral part of radiation therapy. Magnetic resonance imaging (MRI) and computed tomography (CT) provide reliable information about the margins, the effect, and the texture on bone and its vascularity. Fine needle aspiration (FNA) biopsy is a procedure, wherein a thin needle is passed through the skin to take sample tissue or fluid from a solid mass or cyst. The sample from the cyst is extracted through FNA and sent for analysis to a pathology. When a suspicious lump is found, fine needle aspiration biopsy is performed. FNA is a quicker method, non-invasive, and is less painful compared to different methods of tissue sampling. A medical test used to extract a piece of tissue from a lesion or mass is referred as an incisional biopsy. A medical test in which the whole lump or the lesion or the mass is extracted is referred as an excisional biopsy.


Global Paranasal Sinus Cancer Market: Key Trends

Rise in prevalence of chronic diseases, high prevalence of rare cancers, increase in the geriatric population, and technological advancements are projected to drive the global paranasal sinus cancer market. Uncompromising government rules & regulation regarding product approval and high cost of treatment are expected to restrain the market during the forecast period.

Global Paranasal Sinus Cancer Market: Segmentation

The global paranasal sinus cancer market can be segmented based on diagnosis, end-user, and region. In terms of diagnosis, the global market can be classified into imaging tests, biopsy, medical history & physical examination, and others. Imaging tests can be categorized bifurcated into computed tomography scan (CT scan), positron emission tomography scan (PET), X-ray, and magnetic resonance imaging (MRI). Biopsy can be divided into fine needle aspiration biopsy (FNA) and incisional & excisional biopsies. Based on end-user, the global paranasal sinus cancer market can be classified into hospitals & clinics, research laboratories, cancer treatment & research centers, and others.


Global Paranasal Sinus Cancer Market: Regional Analysis

In terms of region, the global paranasal sinus cancer market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to be a prominent market during the forecast period. The region’s dominance is attributed to the strategic presence of key players in the U.S. and Canada.

Global Paranasal Sinus Cancer Market: Competitive Landscape


Key players operating in the global paranasal sinus cancer market are Pfizer, Inc., Eli Lily and Company, AbbVie, Inc., Bristol-Myers Squibb Company, Becton, Dickinson and Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific, Novartis AG, Ipsen Biopharmaceuticals, Inc., Abbott, Agilent Technologies, Inc., GE Healthcare, AstraZeneca, Bayer AG, and Boehringer Ingelheim International GmbH, among others.

Veterinary Biologics Market Demand and Production Overview 2019 to 2027

Global Veterinary Biologics Market: Overview

Immunity is a biological defense mechanism to avoid infection or disease. When the autoimmune system fails, biologic drugs play a vital role in defending against diseases or infections by boosting the immune system. Veterinary biologics are products derived from living organisms and biological processes. These are used to prevent, diagnose, or treat animal diseases and function through an immunological process.


Global Veterinary Biologics Market: Key Trends

Rise in prevalence of animal diseases, increase in disposable income, focus of major players in the research and development of new vet biologic products to combat new animal diseases are projected to drive demand for veterinary biologics products. Moreover, increase in investments by government bodies and rise in demand for milk, meat, eggs, and fish are the other factors anticipated to propel the global veterinary biologics market during the forecast period.


Global Veterinary Biologics Market: Segmentation

The global veterinary biologics market can be segmented based on product, disease type, animal type, distribution channel, and region. In terms of product, the global market can be classified into vaccines, diagnostic kits, immunomodulators, antiserums & antibodies, and others. The vaccines segment can be categorized into inactivated vaccines, conjugate vaccines, live attenuated, and toxoid vaccines. The vaccines segment is projected to account for significant share of the market in the near future. This is because of technological advances in vaccine development, continuous development of drug resistance by pathogens, and emergence of new diseases. Moreover, veterinary vaccine development generally has less stringent regulatory and preclinical trial requirements. Therefore, new players have the opportunity to enter the market through new product development. Based on animal type, the global veterinary biologics market can be bifurcated into livestock animals and companion animals. Usage of veterinary biologics is higher in livestock animals. Hence, the livestock animals segment is anticipated to dominate the market. Livestock animals are more prone to new diseases. Hence, proper vaccination is required. In terms of disease type, the market can be divided into bluetongue, foot & mouth disease, brucellosis & tuberculosis, and others. Based on distribution channel, the global veterinary biologics market can be classified into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment dominated the market in 2017 due to favorable government support and availability of all types of vet treatment.


Global Veterinary Biologics Market: Regional Analysis

In terms of region, the global veterinary biologics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for significant share of the global veterinary biologics market during the forecast period, owing to increase in concerns about pet health and high cost of products. Favorable government support for the development of new biologic drugs is anticipated to drive the market in Europe. In December 2015, the Biotechnology and Biological Sciences Research Council (BBSRC) funded GBP 5.7 Mn for the development of poultry vaccines to the London School of Hygiene and Tropical Medicine. A rising trend of zoonotics, mandatory government requirement for immunization of animals, and trend of keeping companion animals are the major factors that drive the veterinary biologics market in Asia Pacific.

Global Veterinary Biologics Market: Competitive Landscape


Major players operating in the global veterinary biologics market include Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, and Hebei Veyong Animal Pharmaceutical Co., Ltd.

Dental Thermosealers Market by Application, Trends and Growth Rate to 2026

Global Dental Thermosealers Market: Overview

Dental thermosealers are medical devices or machines used to seal surgical instruments before placing them inside the autoclave for sterilization. They are used in sterilization procedures for dental instruments. They preserve the sterility of the dental instruments at the end of the sterilization cycle. Thermosealers seal dental equipment for sterilization by using heat and pressure method. Dental thermosealers are used with sterilization tubing and similar materials to create custom-sized sterilization packaging. These simple devices heat up quickly and allow the packaging material to be placed beneath an arm that presses it into the heating element to create a proper seal for the sterilization process. A dental thermosealer should fit on a counter in the sterilization center for easy access.


Global Dental Thermosealers Market: Key Trends

A rise in the prevalence of dental diseases and increase in the patient pool are major drivers for the growth of the global dental thermosealers market. For instance, as per WHO, in 2010, untreated caries in permanent teeth was prevalent in 2.4 billion people globally. Data also shows that 621 million children were affected by caries worldwide in 2010. Increased awareness regarding sterilization and rise in the use of sterilization devices for patient safety are also some of the major factors that are propelling the growth of the global dental thermosealers market. Additionally, advanced technologies for sterilization procedures and R&D activities for dental procedures are also contributing to the growth of the global dental thermosealers market. However, high cost of devices and difficulty in maintaining the devices are projected to hinder the growth of the global dental thermosealers market.


Global Dental Thermosealers Market: Segmentation

The global dental thermosealers market can be segmented based on product, technology, end-user, and region. In terms of product, the global dental thermosealers market can be classified into automatic and semiautomatic. The automatic segment is dominant and is expected to maintain its position during the forecast period. The segment is expected to expand at a rapid CAGR during the forecast period, as dental thermosealers offer faster operation and ease of handling the entire process of thermo sealing. Based on technology, the global dental thermosealers market can be segmented into rotary, impulse, and band technology segments. The rotary segment dominated the market and is expected to expand at a significant CAGR during the forecast period. This is because rotary dental thermosealers offer greater control of handling and are suitable for all types of equipment. In terms of end-user, the global dental thermosealers market can be classified into hospitals, dental clinics and others (ambulatory surgery centers and dental diagnostic centers). The hospitals segment constituted a prominent market share in terms of revenue and is expected to dominate the market during the forecast period. The growth of the hospitals segment of the dental thermosealers market can be attributed to lower cost of dental procedures at hospitals as compared to private clinics and more number of hospitals opted for this equipment for sterilization across globe. Moreover, specialty dentists are available at hospitals and safety measures such as standard sterilization procedures are adopted. These factors are estimated to propel the segment. The dental clinics segment is expected to expand at a robust CAGR in the coming years, due to a rise in the number of specialty clinics and increase in people’s inclination toward specialized treatments available at these clinics.


Global Dental Thermosealers Market: Regional Analysis

In terms of region, the global dental thermosealers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was a dominant region of the market. The market in the region is expected to expand at a rapid pace in the next few years. A rise in the prevalence of dental diseases, presence of major players, and higher safety standards adopted during dental procedures in the region are projected to drive the dental thermosealers market in North America. Asia Pacific is a lucrative region of the dental thermosealers market. The market in the region is expected to expand at a rapid CAGR during the forecast period, due to a larger patient pool and increased awareness regarding dental procedures.

Global Dental Thermosealers Market: Competitive Landscape

The global dental thermosealers market is highly competitive, due to the presence of major companies in this market. Key players operating in the global dental thermosealers market include Dental X S.p.A., Dentsply Sirona, Medical Trading s.r.l., Ningbo Runyes Medical Instrument Co., Ltd., BA International Ltd., hawo GmbH, Gandus Saldatrici srl, Ritter Concept, MDS Medical Ltd., and Reverberi s.r.l.


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.